Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.3389/fimmu.2020.01784

http://scihub22266oqcxt.onion/10.3389/fimmu.2020.01784
suck pdf from google scholar
32849643!7399176!32849643
unlimited free pdf from europmc32849643    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32849643      Front+Immunol 2020 ; 11 (ä): 1784
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches #MMPMID32849643
  • Dong R; Chu Z; Yu F; Zha Y
  • Front Immunol 2020[]; 11 (ä): 1784 PMID32849643show ga
  • COVID-19 has recently become the most serious threat to public health, and its prevalence has been increasing at an alarming rate. The incubation period for the virus is ~1-14 days and all age groups may be susceptible to a fatality rate of about 5.9%. COVID-19 is caused by a novel single-stranded, positive (+) sense RNA beta coronavirus. The development of a vaccine for SARS-CoV-2 is an urgent need worldwide. Immunoinformatics approaches are both cost-effective and convenient, as in silico predictions can reduce the number of experiments needed. In this study, with the aid of immunoinformatics tools, we tried to design a multi-epitope vaccine that can be used for the prevention and treatment of COVID-19. The epitopes were computed by using B cells, cytotoxic T lymphocytes (CTL), and helper T lymphocytes (HTL) base on the proteins of SARS-CoV-2. A vaccine was devised by fusing together the B cell, HTL, and CTL epitopes with linkers. To enhance the immunogenicity, the beta-defensin (45 mer) amino acid sequence, and pan-HLA DR binding epitopes (13aa) were adjoined to the N-terminal of the vaccine with the help of the EAAAK linker. To enable the intracellular delivery of the modeled vaccine, a TAT sequence (11aa) was appended to C-terminal. Linkers play vital roles in producing an extended conformation (flexibility), protein folding, and separation of functional domains, and therefore, make the protein structure more stable. The secondary and three-dimensional (3D) structure of the final vaccine was then predicted. Furthermore, the complex between the final vaccine and immune receptors (toll-like receptor-3 (TLR-3), major histocompatibility complex (MHC-I), and MHC-II) were evaluated by molecular docking. Lastly, to confirm the expression of the designed vaccine, the mRNA of the vaccine was enhanced with the aid of the Java Codon Adaptation Tool, and the secondary structure was generated from Mfold. Then we performed in silico cloning. The final vaccine requires experimental validation to determine its safety and efficacy in controlling SARS-CoV-2 infections.
  • |Amino Acid Sequence[MESH]
  • |Betacoronavirus/*chemistry[MESH]
  • |COVID-19[MESH]
  • |Computational Biology/*methods[MESH]
  • |Coronavirus Infections/*prevention & control/virology[MESH]
  • |Epitopes, B-Lymphocyte/*immunology[MESH]
  • |Epitopes, T-Lymphocyte/*immunology[MESH]
  • |HLA-DR Antigens/immunology[MESH]
  • |Humans[MESH]
  • |Immunogenicity, Vaccine[MESH]
  • |Molecular Docking Simulation[MESH]
  • |Pandemics/*prevention & control[MESH]
  • |Pneumonia, Viral/*prevention & control/virology[MESH]
  • |Protein Folding[MESH]
  • |Protein Structure, Tertiary[MESH]
  • |SARS-CoV-2[MESH]
  • |T-Lymphocytes, Cytotoxic/immunology[MESH]
  • |T-Lymphocytes, Helper-Inducer/immunology[MESH]
  • |Vaccines, Subunit/immunology[MESH]
  • |Viral Proteins/*immunology[MESH]
  • |Viral Vaccines/*immunology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box